AJP - Renal  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F438, 2007; doi:10.1152/ajprenal.00092.2007
0363-6127/07 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaustein, M. P.
Right arrow Articles by Pallone, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaustein, M. P.
Right arrow Articles by Pallone, T. L.

LETTERS TO THE EDITOR

Sodium pumps: ouabain, ion transport, and signaling in hypertension

Mordecai P. Blaustein,1,,2 John M. Hamlyn,1 and Thomas L. Pallone1,2

Departments of 1Physiology and 2Medicine, University of Maryland School of Medicine, Baltimore, Maryland

TO THE EDITOR: A recent Editorial Focus in this journal (7) addresses the newly recognized role of the sodium pump as both an ion transport protein and a hormone receptor with its own signaling cascade. The relative importance of the cardiotonic steroids (CTS) as endogenous signaling hormones versus their ability to inhibit the sodium pump is of great interest. Indeed, the article noted that "although all digitalis-like compounds inhibit Na-K-ATPase-mediated transport, they differ considerably in terms of their hypertensive effects." The author concludes that "these findings do not support the prevailing hypothesis that the pathophysiological effect of digitalis results from inhibition of... transport activity." This implies that the hypertensive effect of CTS may be due to the action of these agents as regulators of signal transduction, entirely unrelated "to its (Na-K-ATPase's) role as an ion pump." The discoveries related to Src kinase-mediated signal transduction by Na-K-ATPase add a new dimension to the view that the endogenous cardiotonic steroids comprise a novel hormone system. Nevertheless, the view that CTS induced hypertension is unrelated to inhibition of ion transport is inconsistent with published reports. Regrettably, the Editorial Focus does not cite key articles that support the conclusion that CTS hypertension is secondary to inhibition of sodium pumps.

It is true that the tendency of certain CTS to induce hypertension does not correlate with their relative potency as Na-K-ATPase inhibitors (8, 9). The most obvious comparison is that ouabain induces hypertension while digoxin (1, 9) and a digitoxigenin derivative, PST-2238 (4), are antihypertensive. This need not imply that ouabain's effect on blood pressure is unrelated to inhibition of Na+ transport. Instead, these data are consistent with the interpretation that some CTS have mixed agonist/antagonist properties.

Viability of the hypothesis that enhancement of cytoplasmic Ca2+ responses by ouabain is related to inhibition of Na-K-ATPase relies on the secondary effect of Na+ on Na/Ca exchange. There is now direct evidence that elevation of blood pressure is a consequence of reduced transport activity of the ouabain-sensitive Na-K-ATPase {alpha}2-isoform (2, 3, 10) and the resultant Ca2+ gain mediated by Na/Ca exchange (3, 5, 10). Moreover, reduced {alpha}2 expression leads to murine hypertension (10). The vascular myogenic effect of that model is prevented by the Na/Ca exchange inhibitor SEA0400 (10). A key role for Na/Ca exchange is revealed by the observation that SEA0400 lowers blood pressure in ouabain-induced hypertension and other forms of salt-dependent hypertension, but not salt-independent hypertension (5). These findings demonstrate that ouabain's hypertensive effect depends on its inhibition of the Na-K-ATPase and Ca2+ gain via Na/Ca exchange. Thus Src signaling, alone, appears to be insufficient to raise blood pressure in ouabain-induced hypertension although an accessory role is not excluded.

Comparison of the effect of reduced expression of the {alpha}2 Na-K-ATPase (6) with that of low-dose ouabain on cell signaling may be a useful way to determine the roles of altered Na+ and Ca2+ in mediating the effects of ouabain on Src kinase signaling.

FOOTNOTES


Address for reprint requests and other correspondence: M. P. Blaustein, Univ. of Maryland School of Medicine, 655 West Baltimore St., Baltimore, MD 21201-1559 (e-mail: mblaustein{at}som.umaryland.edu)

REFERENCES

  1. Abarquez RF Jr. Digitalis in the treatment of hypertension. A preliminary report. Acta Med Philipp 3: 161–170, 1967.[Medline]
  2. Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW, Lingrel JB. The {alpha}2 isoform of Na,K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288: H477–H485, 2005.[Abstract/Free Full Text]
  3. Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 102: 15845–15850, 2005.[Abstract/Free Full Text]
  4. Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, Melloni P, Bianchi G. PST 2238: a new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther 288: 1074–1083, 1999.[Abstract/Free Full Text]
  5. Iwamoto T, Kita S, Zhang J, Blaustein MP, Arai Y, Yoshida S, Wakimoto K, Komuro I, Katsuragi T. Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Nature Med 10: 1193–1199, 2004.[CrossRef][Web of Science][Medline]
  6. James PF, Grupp IL, Grupp G, Woo AL, Askew GR, Croyle ML, Welsh RA, Lingrel JB. Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 3: 555–563, 1999.[CrossRef][Web of Science][Medline]
  7. Kaunitz JD. Membrane transport proteins: not just for transport anymore. Am J Physiol Renal Physiol 290: F995–F996, 2006.[Free Full Text]
  8. Manunta P, Hamilton BP, Hamlyn JM. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring. Hypertension 37: 472–477, 2001.[Abstract/Free Full Text]
  9. Manunta P, Hamilton J, Rogowski AC, Hamilton BP, Hamlyn JM. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 23, Suppl: S77–S85, 2000.[CrossRef][Web of Science][Medline]
  10. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG, Blaustein MP. Sodium pump {alpha}2 subunits control myogenic tone and blood pressure in mice. J Physiol 569: 243–256, 2005.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaustein, M. P.
Right arrow Articles by Pallone, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaustein, M. P.
Right arrow Articles by Pallone, T. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.